Table I. Clinical characteristics of study participants in an area of stable malaria transmission in western Kenya.
| HIV Negative, n = 52 | HIV Positive, n = 138 | p Valuea | |
|---|---|---|---|
| Age, y, median (p25, p75)b | 24.6 (21.6, 32.2) | 29.4 (25.3, 36.2) | <0.01 |
| Female sex, n (%) | 25 (48.1) | 84 (60.9) | 0.11 |
| Helminth infection, n (%) | 9 (17.6)c | 31 (22.6)d | 0.46 |
| Malaria blood smear positive, n (%) | 3 (5.8) | 11 (8.0) | 0.61 |
| Bednet use, n (%) | 43 (84.3) | 115 (84.6) | 0.97 |
| CRP, mg/l, median (p25, p75)b | 0.52 (0.27, 1.15) | 4.72 (0.87, 26.12)d | <0.001 |
| WBC × 109 per liter, mean (SD) | 6.31 (1.66)c | 5.95 (2.22)e | 0.30 |
| Lymphocytes, % of WBC, mean (SD) | 32.3 (13.7)c | 33.2 (13.2)f | 0.68 |
| CD4 count (cells per ml), mean, (SD) | 328.6 (228.5)d | ||
| Participants with CD4 < 200, n (%) | 42 (30.7)d | ||
| HIV-1 viral load (copies/ml), median (p25, p75)b | 50370 (14546, 198155)d |
a
p value comparing HIV-negative to HIV-positive participants using χ2 for proportions and Wilcoxon rank sum test for medians.
b
p25, p75 = 25th percentile,75th percentile.
c
n = 51.
d
n = 137.
e
n = 128.
f
n = 129.